- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02877693
A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging (ASIA MRI ICD)
March 1, 2023 updated by: Abbott Medical Devices
To assess the clinical performance of the St. Jude Medical™ MR Conditional ICD System in patients undergoing an elective thoracic MRI scan.
Study Overview
Detailed Description
This clinical investigation is a prospective, multicenter, Asian study.
The study was designed with two (2) parts, however only the 1st part was completed.
For the 1st part, patients were enrolled with a SJM MR Conditional ICD System approved for thoracic scan with 1.5 Tesla MRI scanning machines.
The 2nd part-meant to enroll patients for thoracic scans with 3 Tesla MRI scanning machines-was not completed.
Study Type
Interventional
Enrollment (Actual)
205
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chandigarh, India, 160012
- Post Graduate Institute of Medical Education & Research
-
Delhi, India, 110005
- BLK Super Speciality Hospital
-
Delhi, India, 110017
- MAX Super Specialty Hospital
-
Delhi, India, 110017
- Pushpawati Singhania Research Institute
-
Delhi, India
- Apollo Gleneagles Hospital
-
Delhi, India
- Batra Hospital & Medical Research Centre
-
Delhi, India
- Fortis Flt. Lt. Rajan Dhall Hospital
-
Delhi, India
- National Heart Institute
-
Gurgaon, India, 122001
- Medanta Medicity Hospital
-
Hyderabad, India, 500034
- Care hospital
-
Mumbai, India, 400051
- Asian Heart Institute
-
New Delhi, India
- Escorts Heart Institute and Research Centre
-
Pune, India, 411001
- Ruby Hall Clinic
-
-
Haryana
-
Gurgaon, Haryana, India, 122001
- Medanta-The Medicity
-
-
-
-
-
Cheonan, Korea, Republic of
- Dankook University Hospital
-
Seongnam-si, Korea, Republic of
- CHA Bundang Medical Center
-
Seoul, Korea, Republic of
- Seoul National University Hospital
-
Seoul, Korea, Republic of
- Severance Hospital
-
Seoul, Korea, Republic of
- Seoul St. Mary Hospital
-
-
-
-
-
Kajang, Malaysia
- Hospital Serdang
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Subject is pectorally implanted with St. Jude Medical™ MR Conditional ICD System for at least 60 days
- Subject is willing to undergo an elective MRI scan without sedation NOTE: Antianxiety agents (e.g. minor tranquilizers, etc.) may be used as long as the patient can communicate with site personnel during the MRI scan
- Subject's ventricular bipolar capture threshold is stable < 2.5V @ 0.5ms
- Subject's ventricular sensing is measurable (patient has underlying rhythm > 30bpm) and the sensing amplitude is stable > 4mV
- Subject is able to provide informed consent for study participation (legal guardian or legally authorized representative is NOT acceptable)
- Subject is willing and able to comply with the prescribed follow-up tests and procedures
- Subject is not contraindicated for an MRI scan (per the MRI Screening Form)
Exclusion Criteria:
- Subject is pacemaker dependent
- Subject has a non SJM MRI compatible endocardial lead implanted or capped
- Subject has another existing active implanted medical device, e.g., neurostimulator, infusion pump, etc. that has MR labeling that will not allow the MRI scans per this protocol to be completed.
- Subject has a high voltage lead revision incidence < 60 days of the enrollment visit
- Subject has other non-MRI compatible device or material implanted NOTE: MRI compatible knee replacements, hip replacements, stents, etc. may be included as long as the labeling of these devices allow MRI scans conducted per this protocol NOTE: MRI compatible mechanical, prosthetic, and bioprosthetic heart valves may be included as long as the labeling of these devices allow for MRI scans conducted per this protocol NOTE: Non-removable dental implants may be included
- Subject has a lead extender, adaptor, or capped/abandoned lead
- Subject is enrolled or intend to participate in a clinical drug and/or device study (investigational device, investigational drug, new indication for a device or drug or additional testing beyond standard of care procedures), which could confound the results of this trial as determined by SJM.
- Subject is pregnant or planning to become pregnant during the duration of the subject's participation in the study
- Subject has a life expectancy of less than 12 months due to any condition
- Subject has exclusion criteria required by local law (e.g., age)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Thoracic MRI Scan with 1.5 Tesla MRI
Subjects will be enrolled at least 60 days post successful St. Jude Medical™ MR Conditional ICD System implant.
Enrolled subjects will undergo an elective 1.5T MRI scan within 30 days post enrollment.
Post MRI visit all subjects will be followed up at 1-Month post MRI visit.
|
The ICD system will be exposed to MRI scan of thoracic region, where the radiofrequency (RF) component of the scan is maximized.
|
|
Experimental: Thoracic MRI Scan with 3 Tesla MRI
Subjects will be enrolled at least 60 days post successful St. Jude Medical™ MR Conditional ICD System implant.
Enrolled subjects will undergo an elective 3T MRI scan within 30 days post enrollment.
Post MRI visit all subjects will be followed up at 1-Month post MRI visit.
|
The ICD system will be exposed to MRI scan of thoracic region, where the radiofrequency (RF) component of the scan is maximized.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Freedom From MRI-scan Related Complications* Related to St. Jude Medical™ MR Conditional ICD System
Time Frame: from MRI scan visit to 1 month post-MRI scan visit
|
*A complication is a serious adverse device effect (SADE) that requires an invasive intervention or leads to death. The primary endpoint analysis will be performed for each study phase separately. |
from MRI scan visit to 1 month post-MRI scan visit
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Average Specific Absorption Rate (SAR)
Time Frame: MRI scan visit
|
The average Specific Absorption Rate (SAR) during the MRI scan
|
MRI scan visit
|
|
Number of Participants With Freedom From MRI-scan Related Complications* Related to St. Jude Medical™ MR Conditional ICD System
Time Frame: from MRI scan visit to 1-month post MRI scan visit
|
This proportion was calculated as the number of subjects who had high voltage leads with capture threshold increases of ≤ 0.5V @ 0.5 ms from pre MRI scan testing to 1-month post MRI scan testing divided by total number of subjects who had high voltage lead implanted, underwent an MRI scan and had both pre-MRI scan and 1-month post MRI scan capture threshold measurements available.
|
from MRI scan visit to 1-month post MRI scan visit
|
|
Proportion of SJM High Voltage Lead Implanted With SJM MR Conditional ICD With Sensing Amplitude Decrease of ≤ 50% From Pre-MRI Scan Testing to 1 Month Post-MRI Scan Testing
Time Frame: from pre MRI scan to 1-month post MRI scan
|
This proportion was calculated as the number of subjects who had high voltage leads with sensing amplitude decrease of ≤ 50% from pre MRI scan testing to 1 month post MRI scan testing divided by the total number of subjects who had high voltage lead implanted, underwent an MRI scan and had both pre MRI scan and 1 month post MRI scan sensing amplitudes available.
|
from pre MRI scan to 1-month post MRI scan
|
|
The Peak Specific Absorption Rate (SAR) During the MRI Scan
Time Frame: MRI Scan Visit
|
The peak Specific Absorption Rate (SAR) during the MRI scan
|
MRI Scan Visit
|
|
The Mean MRI Visit Duration in the MRI Lab
Time Frame: MRI Visit
|
The mean MRI visit duration in the MRI lab
|
MRI Visit
|
|
Total MRI Scan Duration in MRI Laboratory
Time Frame: MRI Visit
|
Total MRI scan duration in MRI laboratory
|
MRI Visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Grant Kim, St. Jude Medical, Inc.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tarlochan Singh Kler, Praveen Chandra, Chandrakant Chavan, Rajesh Vijayvergiya, Subhash Chandra, Anoop Gupta, Sridevi Chennapragada, Joung Bo Young, Mona Bhatia, Choi Eue Keun, Vanita Arora, Tom Devasia, Upendra Kaul, Sumit Anand, Kartikeya Bhargava. Initial experience of thoracic Magnetic Resonance Imaging (MRI) scanning in Asian patients implanted the Ellipse MR Conditional ICD System - The ASIA MRI ICD Study. APHRS 2017; Abstract no. 40528.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 10, 2016
Primary Completion (Actual)
March 23, 2020
Study Completion (Actual)
March 23, 2020
Study Registration Dates
First Submitted
August 19, 2016
First Submitted That Met QC Criteria
August 23, 2016
First Posted (Estimated)
August 24, 2016
Study Record Updates
Last Update Posted (Estimated)
December 8, 2023
Last Update Submitted That Met QC Criteria
March 1, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJM-CIP-10163
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tachycardia
-
Shanghai MicroPort EP MedTech Co., Ltd.CompletedParoxysmal Supraventricular Tachycardia | Atrioventricular Nodal Reentrant Tachycardia | Atrioventricular Reciprocating TachycardiaChina
-
Erasmus Medical CenterUnknownTachycardia, Supraventricular | Tachycardia; Paroxysmal, SupraventricularNetherlands
-
Marmara University Pendik Training and Research...RecruitingSupraventricular Tachycardia | Paroxysmal Supraventricular Tachycardia | Atrioventricular Nodal Reentry Tachycardia | Vagal ManeuverTurkey (Türkiye)
-
University of PretoriaCompletedSupra-ventricular TachycardiaSouth Africa
-
Medtronic Cardiac Ablation SolutionsCompletedHeart Disease | Supraventricular Tachycardia | AtrioVentricular Nodal Reentrant TachycardiaUnited States, Canada
-
Rashid Latif Medical CollegePunjab Institute of Cardology; Himmel Pharmaceutical private limited, PakistanRecruitingSupraventricular Tachycardia (SVtach)Pakistan
-
Princess Margaret Hospital, Hong KongUnknownSupraventricular Tachycardia | Atrioventricular Nodal Reentrant TachycardiaChina
-
Milestone Pharmaceuticals Inc.Medpace, Inc.CompletedParoxysmal Supraventricular Tachycardia (PSVT)United States, Canada
-
Milestone Pharmaceuticals Inc.TerminatedParoxysmal Supraventricular Tachycardia (PSVT)United States
-
Haseki Training and Research HospitalCompletedSupraventricular Tachycardia (SVT) | Atrioventricular Nodal Re Entrant TachycardiaTurkey (Türkiye)
Clinical Trials on Thoracic MRI Scan
-
University of LeicesterNational Institute for Health Research, United KingdomCompletedPatients With Heart Failure and Preserved Ejection Fraction - HFpEF | Patients With Heart Failure With Reduced Ejection Fraction - HFrEF | Healthy Controls Group - Age and Sex-matched
-
University Hospital, Strasbourg, FranceVISIBLE PATIENT, E-MEDIARecruitingSARS-CoV-2 Infection | Respiratory Failure With HypoxiaFrance
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompletedAspirated Foreign Body of Lower Respiratory TractFrance
-
University Hospital, Strasbourg, FranceREGION GRAND EST; E-MEDIA; VISIBLE PATIENTRecruitingRespiratory Failure With Hypoxia | SARS-CoV-2 InfectionsFrance
-
Poitiers University HospitalUnknownThe Gold Standard for Current SARS CoV2 Detection is RT-PCRFrance
-
University of ChicagoNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Jeffrey A. Lieberman, MDTerminated
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)TerminatedSchizophreniaUnited States
-
Radboud University Medical CenterCompletedHead and Neck NeoplasmsNetherlands
-
The Clatterbridge Cancer Centre NHS Foundation...Unknown